RNA Interference (RNAi) Drug Delivery Report

By www.reportprimer.com

Report Details

Report Name

Global And United States RNA Interference (RNAi) Drug Delivery Market Report & Forecast 2024-2031 Story

Pages

106

Price

$ 4350

Features

RNA Interference (RNAi) Drug Delivery Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Metabolic disorders
Alnylam Pharmaceuticals Inc
Merck & Co. Inc
Access Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Calondo Pharmaceuticals Inc
Marina Biotech Inc
RXi Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Silence Therapeutics plc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc
Traversa Therapeutics Inc